PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$2.83+0.06 (+2.17%)
Close on Oct 19, 2026Market cap $1.13MP/E –Yield –
PMGC shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
PMGC's shares outstanding was 1M at Sep 30, 2026. For fiscal 2025 it was 0M, up 2049.1% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +2049.1% |
| FY2024 | Dec 31, 2024 | 0M | -87.7% |
| FY2023 | Dec 31, 2023 | 0M | +12.8% |
| FY2022 | Dec 31, 2022 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1M | +5297.4% |
| Q2 FY2026 | Jun 30, 2026 | 5M | +75096.6% |
| Q1 FY2026 | Mar 31, 2026 | 0M | +9729.9% |
| Q3 FY2025 | Sep 30, 2025 | 0M | -83.2% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +19.6% |
| Q1 FY2025 | Mar 31, 2025 | 0M | -31.7% |
| Q3 FY2024 | Sep 30, 2024 | 0M | -36.8% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +83.4% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +78.6% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +39.3% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +5.2% |
| Q2 FY2023 | Jun 30, 2023 | 0M | – |
| Q1 FY2023 | Mar 31, 2023 | 0M | – |
| Q4 FY2022 | Dec 31, 2022 | 0M | – |
| Q3 FY2022 | Sep 30, 2022 | 0M | – |
See a number that looks wrong?